| Serial Number | 79304640 |
| Word Mark | TIGEN |
| Filing Date | Friday, November 13, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 22, 2022 |
| Registration Number | 6674502 |
| Registration Date | Tuesday, March 22, 2022 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 4, 2022 |
| Goods and Services | Pharmaceutical products and medical preparations, namely, gene-modified and non-gene-modified cellular therapies for the treatment of localized and systemic malignant hematological and oncological diseases, genetic diseases, autoimmune diseases and infectious diseases |
| Goods and Services | Chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in industry and science; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides and proteins, for use in the development being the manufacture, and manufacture of reagents for industrial or scientific use; chemical, biochemical, biological and biotechnological preparations, namely, polypeptides or proteins, for use of laboratories, diagnostics and analyses for industrial or scientific use; chemical, biochemical, biological and biotechnological substances, namely, polypeptides and proteins, for use in the manufacture of pharmaceuticals |
| Goods and Services | Medical services; pharmacy advice services, namely, pharmaceutical consultation; medical clinic services provided by medical laboratories for diagnostic purposes; preparation and dispensing of medication; preparation of prescriptions by pharmacists |
| Goods and Services | Medical instruments, equipment and apparatus, namely, instruments, equipment and apparatus for cell and cell material collection, thawing, washing, selection, expansion, modification, harvesting, final formulation, freezing, storage and infusion into a patient in the fields of genetic diseases, autoimmune diseases, infectious diseases, localized and systemic malignant hematological and oncological diseases and other cell and cell-material based diseases and conditions |
| Goods and Services | Scientific research, technological development of new products for third parties; medical research; scientific and industrial research in biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious and tumor diseases; research in the field of biomedical and phytopharmaceutical technology; scientific laboratory services; pharmaceutical research and development services; scientific services, namely, development of medicines, active substances and vaccines; scientific services, namely, development of food supplement; design and development of computer hardware and software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; upgrading, maintenance and rental of computer software; updating, maintenance and rental of computer software for use in medical and scientific research and in the development of new products, in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; software as a service (SaaS) services featuring software for controlling end-to-end process development, manufacturing, quality, and supply chain steps and featuring artificial intelligence search engine software to be used in medical and scientific research and in the development of new products in research and development of new products in the field of biotechnology, biology, diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases and the treatment of diseases, genetic diseases, autoimmune diseases, infectious diseases and tumor diseases; chemical and biological laboratory services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 19, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 19, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 19, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 19, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 19, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Tigen Pharma SA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | CH |
| Party Name | Tigen Pharma SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | CH |
| Party Name | Tigen Pharma SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | CH |
| Event Date | Event Description |
| Thursday, February 18, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, February 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 20, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, August 27, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, February 23, 2021 | APPLICATION FILING RECEIPT MAILED |
| Saturday, April 24, 2021 | ASSIGNED TO EXAMINER |
| Monday, May 3, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 4, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, May 7, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, May 7, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, May 31, 2021 | REFUSAL PROCESSED BY IB |
| Monday, November 8, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 8, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 8, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, November 29, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, November 29, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, November 29, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, November 29, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, November 29, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 15, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, December 15, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 15, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Saturday, January 1, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, January 4, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 4, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, August 15, 2022 | FINAL DISPOSITION PROCESSED |
| Monday, August 15, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, September 5, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, March 22, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, June 22, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, June 6, 2025 | LIMITATION OF GOODS RECEIVED FROM IB |
| Sunday, December 31, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, June 13, 2025 | LIMITATION OF GOODS RECEIVED FROM IB |